BioLineRx Ltd (BLRX)

[midastouch017]

BiolineRx: COMBAT Engagement


https://seekingalpha.com/article/4063493-biolinerx-hands-report-combat-station?app=1&auth_param=3ofmh:1cfffra:fafa437f7c0f8c052edd5c95d335a843&uprof=45#alt2

From my point of view, COMBAT and CXCessoR4 have nothing in common except for the targets of the drugs, so Bristol-Myers' failure is not a red flag for BiolineRx. The two combination therapies are different and this is best shown by way companies decided to administrate them. BiolineRx's approach seems very well reasoned and I believe that their trial could have a better chance of success so, to sum up, this COMBAT is worth the fight.

Disclosure: I/we have no positions in any stocks mentioned, but may initiate a long position in BLRX over the next 72 hours.